<DOC>
	<DOCNO>NCT01638767</DOCNO>
	<brief_summary>Presently , long protocol In Vitro Fertilization ( IVF ) cycle , patient need take Marvelon , drug inhibits follicular development begin cycle order well control also plan onset ovary stimulation gonadotropin . Marvelon take daily soon menstruation start period 14 21 day . Ideally , take time everyday forgotten . This may cause high stress level user . Presently market , ring-shaped contraceptive device insert vagina day 1 cycle call NuvaRing . The purpose device similar oral contraceptive . However , benefit NuvaRing leave place period 35 day without manipulation keep adequate rate hormone contraception . Moreover , NuvaRing show well hormone stability blood . Although side effect benefit comparable two treatment , study show patient would respect treatment NuvaRing level satisfaction would higher woman use NuvaRing contraception need . The purpose study compare rate satisfaction well level stress woman use Marvelon daily NuvaRing single insertion long protocol . Moreover , study allow u verify use NuvaRing , vaginal contraceptive release constant daily dose 35 day allow u facilitate planning In Vitro Fertilization cycle long protocol .</brief_summary>
	<brief_title>NuvaRing Versus Marvelon Coordination In Vitro Fertilization Cycles</brief_title>
	<detailed_description>For purpose randomize , control , open-label study , woman select undergoing vitro fertilization treatment long protocol prescription . This study compare two treatment group , one use Marvelon , use NuvaRing . Patients Marvelon take medication period range 14 21 day . This period determine administrative nurse . In contrast , patient NuvaRing group insert vaginal ring period specify administrative nurse , range 14 35 day . During medical consultation , couple assess primary secondary infertility diagnosis establish . Before treatment start , couple undergo series test per standard care order allow diagnosis make determine whether In Vitro Fertilization right treatment . The couple receive information need In Vitro Fertilization cycle . If patient eligible In Vitro Fertilization cycle accord initial assessment physician , patient inform physician research project . After period consideration question answer , couple sign consent form start In Vitro Fertilization treatment study protocol After sign consent form , subject eligible research project , research nurse meet patient . The study explain detail question answer . In addition , nurse record information patient 's medical history include medical history , medication previous surgery . The subject screen eligibility prior randomization . Once subject deem eligible interested participating study , research nurse meet subject order sign inform consent form determine randomization group participate . In order determine group allocate subject , randomized envelope give patient contain patient number open assign one two group â€” either Marvelon NuvaRing group . She open site The randomization carry use envelope system identify initially randomization number . The envelope prepare advance way nobody know content .</detailed_description>
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Ethinyl Estradiol</mesh_term>
	<mesh_term>Desogestrel</mesh_term>
	<mesh_term>Contraceptive Agents</mesh_term>
	<mesh_term>Contraceptives , Oral</mesh_term>
	<criteria>Signed consent form Age 18 time selection In Vitro Fertilization referral Complete normal preIn Vitro Fertilization checkup Long protocol prescription No previous participation project previous cycle Simultaneous participation another interventional research project Contraindications pregnant carry pregnancy full term Contraindications take standard medication long protocol Contraindications take Marvelon use NuvaRing ( Uncontrolled high blood pressure , uncontrolled diabetes , active hepatic infection , benign malignant hepatic tumor , diagnose breast cancer , diagnose suspect estrogendependant neoplasia , ocular suspect lesion , history thrombophlebitis , cardiac arrest , coronary heart disease . ) Patient present vaginal abnormality could unable insert NuvaRing Cervicitis , vaginitis , erosio portionis bleeding , cervical prolapse , cystocele , rectocele , severe chronic constipation , dyspareunia problem sexual intercourse Patient receive research medication 30 day visit 1 Patient unable communicate adequately researcher Patient incapable give informed consent Any ovarian abdominal abnormality could interfere adequate sonographic evaluation Use follow medication : Clonidine Anticoagulants ( anovulant pretreatment ) Anticonvulsants Oral insulin hypoglycemia drug Hypertension drug ( beta blocker ) Aminocaproic acid Beta mimetics ( isoproterenol ) Prednisone Ciclosporin Meperidine Phenothiazine reserpine Chlordiazepoxide , Lorazepam , Oxazepam , Diazepam ( anovulant pretreatment ) Theophylline Clomipramine Vitamin B12 Hypericum perforatumbased product</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>43 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>In Vitro Fertilization long protocol</keyword>
	<keyword>NuvaRing</keyword>
	<keyword>Marvelon</keyword>
	<keyword>In vitro fertilization</keyword>
</DOC>